参考文献：[1] Tosi LL, Bone,2015.76:67-75;Boycott KM, et al, Nat Rev Genet, 2013,14(10)681-91[2] Unger S,et al, Am J Med Genet A.2023.191(5):1164-1209[3] 《2022年中国罕见病临床诊疗现状调研报告》[4] Zhang Z, Xia W, He J, et al, Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy. Am J Hum Genet. 2012 Jan 13;90(1):125-32.[5] 《2024中国罕见病行业趋势观察报告》[6] 《2023年遗传性骨病分类学》[7] Felicia Cosman, E Michael Lewiecki, Richard Eastell, et al, Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024, Journal of Bone and Mineral Research, Volume 39, Issue 10, October 2024, Pages 1393–1405.[8] Balasubramanian A, Zhang , Chen L, et al. Risk of subsequent fracture afer prior fracture among older women. Osteoporos Int. 2019:30(1):79-92.[9] Saag KG,et al.N EnglJ Med.2017:377(15):1417-1427.[10] Kendler DL,et al.Lancet. 2018:391(10117):230-240.[11] Bouxsein Ml,et al.Change in Bone Density and Reduction in fracture Risk: A Meta-Regression of published Trials. J Bone Miner Res. 2019;344):632-642.[12] Wasnich RD, Miller PD. Antifrachre eficacy of antiresorptive agents are related to changes in bone density. I Clin Endocrinol Metab. 2000;85(1):231-6[13] Tai TW, Chen HY, Shih CA, et al, Asia-Pacific consensus on long-term and sequential therapy for osteoporosis. Osteoporos Sarcopenia. 2024 Mar;10(1):3-10.[14] Kanis JA, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019 Jan;30(1):3-44.[15] Ip TP, Lee CA, Lui TD, et al, 2024 OSHK Guideline for Clinical Management of Postmenopausal Osteoporosis in Hong Kong. Hong Kong Med J. 2024 Apr;30 Suppl 2:1-44.[16] Tsourdi E, Zillikens MC, Meier C, et al, Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. J Clin Endocrinol Metab. 2020 Oct 26:dgaa756. 本文來源：医学界内分泌频道责任编辑：卡带
